A very common sexually transmitted virus isn’t responsible for only cervical cancer, and thousands of other cancer cases may be prevented though expanded vaccine use, according to a leading Johns Hopkins researcher.

“If we are going to have a public policy discussion about the full potential of the vaccine, it should be inclusive of these other cancers,” said Dr. Maura Gillison, a researcher in the Hopkins Kimmel Cancer Center.